Anti-inflammatory effects of PGE₂ in the lung: role of the EP₄ receptor subtype

Abstract

This study demonstrates that EP4 receptor activation is responsible for the anti-inflammatory activity of PGE2 in a range of disease relevant models and, as such, could represent a novel therapeutic target for chronic airway inflammatory conditions.